Form 4: Definitive Healthcare CEO Kevin Coop Reports Stock Transactions
SEC Form 4 Filing
Definitive Healthcare Corp. CEO Kevin Coop reports acquisition of stock and holding of restricted stock units.
Summary
- On March 1, 2025, Kevin Coop, the CEO of Definitive Healthcare Corp., reported a transaction involving Class A Common Stock.
- Coop acquired 2,382,892 shares of Class A Common Stock at $0.
- Following the transaction, Coop directly owns 3,739,131 shares.
- The report also mentions restricted stock units (RSUs) that vest over time, starting March 1, 2026, with 25% vesting initially and the remainder vesting quarterly over three years, contingent upon continued service.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock transactions by an insider. The acquisition of shares and vesting RSUs are generally positive signals, but the document itself is simply a factual report.
Positives
- The CEO's acquisition of shares could be interpreted positively, signaling confidence in the company's future.
Future Outlook
The vesting schedule of the RSUs indicates a long-term incentive plan for the CEO, aligning his interests with the company's performance over the next three years.
Industry Context
Form 4 filings are standard disclosures for corporate insiders and provide transparency into their transactions in the company's stock. This filing indicates the CEO's ongoing equity stake in the company.
Comparison to Industry Standards
- Equity compensation in the form of RSUs is a common practice among publicly traded companies to incentivize executives.
- Vesting schedules typically range from three to five years, with quarterly or annual vesting intervals.
- The specific terms of the RSU agreement, such as performance-based vesting conditions, would provide further context for comparison to industry benchmarks.
Stakeholder Impact
- The CEO's increased equity stake could reassure shareholders about his commitment to the company's success.
- Employees may view the CEO's equity stake as a positive sign of leadership confidence.
Key Dates
| Date | Description |
|---|---|
| 03/01/2025 | Date of stock transaction and RSU grant. |
| 03/01/2026 | Initial vesting date for 25% of the restricted stock units. |
| 03/04/2025 | Date of signature on the SEC Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.